{"schema_version":"secwatch.filing_event.v1","accession":"0001520138-24-000006","form_type":"8-K","ticker":"AXIL","cik":"0001718500","company_name":"Axil Brands, Inc.","filed_at":"2024-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.234836+00:00","generated_at":"2026-06-07T04:06:02.710257+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Reviv3 Procare Q2 FY2024 net sales up 25.1% to record $8.4M, net income up 40.1% to $1.02M","bullets":["Net sales record $8.4M (Q2 Nov 30, 2023) vs $6.7M a year ago, up 25.1%.","Net income increased 40.1% to $1.02M from $726,900; sixth consecutive profitable quarter.","Gross margin 74.3% vs 74.9%; operating expenses 59.3% of sales vs 60.2%.","Cash $5.96M (Nov 30, 2023) vs $4.83M (May 31, 2023).","EPS basic $0.01, diluted $0.00; basic shares 117.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-24-000006","json":"https://secwatch.observer/filing/0001520138-24-000006.json","markdown":"https://secwatch.observer/filing/0001520138-24-000006.md","text":"https://secwatch.observer/filing/0001520138-24-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1718500/000152013824000006/0001520138-24-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1718500/000152013824000006/rviv-20240104_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:06:02.710257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c6f69516e3310f7c88ff58fe13e0672e818b7221","claim":"Axil Brands, Inc. reported the second quarter ended November 30, 2023 results: revenue $8.4 million, net income $1,018,075.","evidence_excerpt":"2 rviv-20240104_8kex99z1.htm EXHIBIT 99.1 REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results Net Sales (revenue) increased 25.1% to a record $8.4 million for the second quarter ended November 30, 2023, as compared to the prior year period. Gross Profit (as a percentage of Net Sales) was 74.3% as compared to 74.9% for the prior","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1718500/000152013824000006/0001520138-24-000006-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended November 30, 2023"},{"label":"Revenue","value":"$8.4 million"},{"label":"Net income","value":"$1,018,075"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}